HOME TECHNOLOGY OUR BUSINESS APPLICATIONS PARTNERS INVESTORS CORPORATE CONTACT US PositiveID Corporation™ (OTCQB: PSID) Advanced biological detection and diagnostic solutions for homeland security and global healthcare needs. PositiveID Corporation™ (OTCQB: PSID) is a life sciences tools and diagnostics company specializing in biological detection and molecular diagnostic systems for America’s homeland defense and the global healthcare market. PositiveID specializes in the development of microfluidic systems in order to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need through its ExcitePCR subsidiary. PositiveID is also a leader in the mobile technology vehicle market through its E-N-G Mobile Systems subsidiary. Technology PositiveID develops biological detection and diagnostics systems, including its M-BAND and Firefly Dx systems, which use real-time polymerase chain reaction (PCR) chemistry. PCR amplifies a sample’s DNA and copies it billions of times. PCR is used every day to diagnose diseases, identify bacteria and viruses, and for many other applications. With real-time PCR, the amplification of the DNA can be measured as it occurs, thereby speeding up the ability to deliver results. Real-time PCR is one of the most sensitive and specific bio-detection capabilities available today. Read more >> Products PositiveID develops biological detection and diagnostics systems, including its M-BAND and Firefly Dx technologies. MFS began developing complex microfluidic systems to perform sample processing and purification for the Defense Advanced Projects Agency (DARPA). It then developed a similar system, including a thermal cycler for polymerase chain reaction (PCR) analysis for the US Army’s Edgewood Chemical and Biological Command (ECBC). Read more >> News Wednesday, July 18, 2018 PositiveID Adds Listeria to Pathogens Detected by FireflyDX Onsite Detection Prototype Read more >> Monday, June 25, 2018 PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute’s 26th Biodetection Technologies: Biothreat and Pathogen Detection Read more >> Wednesday, June 20, 2018 PositiveID CEO Details New Distribution Agreement with Leading Non-Invasive Patient Monitoring Technology Company Read more >> Monday, June 11, 2018 PositiveID to Exhibit its Caregiver Non-Contact Thermometer at the Association for Professionals in Infection Control and Epidemiology Annual Conference June 13-15th Read more >> Tuesday, June 5, 2018 PositiveID CSO and Former DHS Chief Scientist Calls for “Nunn-Lugar Act 2.0” to Dismantle Unprecedented Chemical and Biological Weapons Stockpile in North Korea Read more >> PositiveID Corporation™ (OTCQB: PSID) Copyright 2015. All Rights Reserved. Designed by Heather Cummens.